Does the Act on the Safety of Regenerative Medicine in Japan ensure “safety”?: Implications of low adverse event reporting-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Does the Act on the Safety of Regenerative Medicine in Japan ensure “safety”?: Implications of low adverse event reporting

Published:2023-12 Issue:12 Volume:18 Page:2297-2299
ISSN:2213-6711
Container-title:Stem Cell Reports
language:en
Short-container-title:Stem Cell Reports

Author:

Ikka Tsunakuni^ORCID,Hatta Taichi,Saito Yoko,Fujita Misao

Funder

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Cell Biology,Developmental Biology,Genetics,Biochemistry

Reference14 articles.

1. Current status of platelet-rich plasma therapy under the act on the safety of regenerative medicine in Japan;Arita;Regen. Ther.,2023

2. Too little, too soon: Japan’s experiment in regenerative medicine deregulation;Cyranoski;Cell Stem Cell,2023

3. Current status of cell-based interventions in Japan;Fujita;Cell Stem Cell,2022

4. Balancing safety and efficacy with early availability in the regulation of regenerative medicine product;Fujiwara;Clin. Pharmacol. Ther.,2021

5. Difficulties in ensuring review quality performed by committees under the act on the safety of Regenerative Medicine in Japan;Ikka;Stem Cell Rep.,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP